SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-016251
Filing Date
2018-01-22
Accepted
2018-01-22 17:29:56
Documents
6
Period of Report
2018-02-09
Effectiveness Date
2018-01-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d517168ddef14a.htm DEF 14A 525941
2 GRAPHIC g517168g0108220148001.jpg GRAPHIC 5255
3 GRAPHIC g517168g0108220148157.jpg GRAPHIC 3429
4 GRAPHIC g517168image002.jpg GRAPHIC 1826
5 GRAPHIC g517168page092.jpg GRAPHIC 226421
6 GRAPHIC g517168page093.jpg GRAPHIC 149969
  Complete submission text file 0001193125-18-016251.txt   1060381
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37929 | Film No.: 18540637
SIC: 2834 Pharmaceutical Preparations